Recombinant activated factor VII in the management of massive obstetric bleeding.
Palomino
Miguel Angel Prieto
MA
Chaparro
María José S
MJ
de Elvira
Maria José Z Ruiz
MJ
Curiel
Emilio B
EB
D000037:Abruptio Placentae; D002585:Cesarean Section / Q000009:adverse effects; D016527:Drug Costs; D005167:Factor VII / Q000378:metabolism; D015942:Factor VIIa / Q000191:economics / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D005313:Fetal Death; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D013030:Spain
D011994:Recombinant Proteins; D005167:Factor VII; D015942:Factor VIIa